Abbott Laboratories (ABT) This autumn 2024 Earnings Name Transcript


Abbott Laboratories (NYSE:ABT) This autumn 2024 Earnings Convention Name January 22, 2025 9:30 AM ET

Firm Individuals

Mike Comilla – Vice President, Investor Relations
Robert Ford – Chairman & Chief Govt Officer
Phil Boudreau – Govt Vice President, Finance & Chief Monetary Officer

Convention Name Individuals

Robbie Marcus – JPMorgan
Larry Biegelsen – Wells Fargo
Travis Steed – BofA Securities
Vijay Kumar – Evercore ISI
Josh Jennings – TD Cowen
David Roman – Goldman Sachs
Joanne Wuensch – Citi
Danielle Antalffy – UBS
Matt Miksic – Barclays

Operator

Good morning and thanks for standing by. Welcome to Abbott’s Fourth Quarter 2024 Earnings Convention Name. All contributors will be capable of hear solely till the question-and-answer portion of this name. [Operator Instructions] This name is being recorded by Abbott. Apart from any participant’s questions requested through the question-and-answer session, your entire name, together with the question-and-answer session, is materials copyrighted by Abbott. It can’t be recorded or rebroadcast with out Abbott’s categorical written permission.

I might now wish to introduce Mr. Mike Comilla, Vice President, Investor Relations.

Mike Comilla

Good morning and thanks for becoming a member of us. With me at this time are Robert Ford, Chairman and Chief Govt Officer; and Phil Boudreau, Govt Vice President, Finance and Chief Monetary Officer. Robert and Phil will present opening remarks. Following their feedback, we’ll take your questions.

Earlier than we get began, some statements made at this time could also be forward-looking for functions of the Non-public Securities Litigation Reform Act of 1995, together with the anticipated monetary outcomes for 2025. Abbott cautions that these forward-looking statements are topic to dangers and uncertainties that will trigger precise outcomes to vary materially from these indicated within the forward-looking statements. Financial, aggressive, governmental, technological, and different components that will have an effect on Abbott’s operations are mentioned in Merchandise 1A, Threat Elements, to our annual report on Type 10-Ok for the year-ended December 31, 2023. Abbott undertakes



Source link

Related articles

Cease Buying and selling the Unsuitable Pairs: Discover the Greatest Setups in Seconds with Titan FX Energy – Analytics & Forecasts – 25 February...

28 farklı grafike bakıp hangi para birimi çiftinin gerçekten hareket ettiğini anlamaya çalışmaktan yoruldun mu? Çoğu perakende tüccar piyasaya karşı mücadele ettiği için...

Thrive invested $1B in OpenAI in 2025 at a $285B valuation in a transaction akin to a name possibility; OpenAI was individually elevating at...

Featured Podcasts Nice Chat: Again within the enviornment A podcast principally about tech. Delivered to you weekly by Angela Du, Sally Shin, Mac Bohannon, Helen Min, and Ashley Mayer. Subscribe to Nice Chat. Huge Expertise Podcast: Can AI Obtain...

Iran warns of ferocious response to any US army motion

Iran has threatened a fierce response to any US army strike, signaling a...

The Hidden Working Capital Alternative in Your Warehouse

For finance leaders at giant retailers and types, extra...

Aligning Allocation to the International Enterprise Cycle

Asset allocation is anticipated to do a number of issues without delay: earn carry, restrict drawdowns, and rebuild threat publicity early...
spot_img

Latest articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

WP2Social Auto Publish Powered By : XYZScripts.com